Psychomotor symptoms in schizophrenia: The importance of a forgotten syndrome;Psychomotorische symptomen bij schizofrenie: Het belang van een vergeten syndroom

Tijdschrift voor Psychiatrie

Volumn 50, Issue 11, 2008, Pages 713-724

  Morrens, M ^a   Hulstijn, W ^a   Sabbe, B G C ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Catatonia; Extrapyramidal symptoms; Neurological hard signs; Neurological soft signs; Psychomotor slowing; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ABNORMAL INVOLUNTARY MOVEMENT SCALE; AKATHISIA; ARTICLE; BARNES AKATHISIA SCALE; BRADYKINESIA; BUSH FRANCIS CATATONIA RATING SCALE; CATATONIA; DEPRESSION; DRUG INDUCED DISEASE; DYSKINESIA; EXTRAPYRAMIDAL SYMPTOM; GABAERGIC SYSTEM; HUMAN; NEGATIVE SYNDROME; NEUROIMAGING; NEUROLOGIC EXAMINATION; POSITIVE SYNDROME; PROGNOSIS; PSYCHOMOTOR DISORDER; PSYCHOMOTOR RETARDATION; RATING SCALE; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; HUMANS; PSYCHOMOTOR DISORDERS; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX;

EID: 56349106565     PISSN: 03037339     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Adler, L.A., Angrist, B., Reiter, S., e.a. (1989). Neuroleptic-induced akathisia: a review. Psychopharmacology, 97, 1-11.
2. Bachmann, S., Bottmer, C., Schröder, J. (2005). Neurological soft signs in first-episode schizophrenia: a follow-up study. The American Journal of Psychiatry, 162, 2337-2343.
3. Barkus, E., Stirling, J., Hopkins, R., e.a. (2006). The presence of neurological soft signs along the psychosis proneness continuum. Schizophrenia Bulletin, 32, 573-577.
4. Barnes, T.R., Crichton, P., Nelson, H.E., e.a. (1995). Primitive (developmental) reflexes, tardive dyskinesia and intellectual impairment in schizophrenia. Schizophrenia Research, 16, 47-52.
5. Bersani, G., Paolemili, M., Quartini, A., e.a. (2007). Neurological soft signs and cerebral measurements investigated by means of MRI in schizophrenic patients. Neuroscience Letters, 413, 82-87.
6. Bersani, G., Gherardelli, S., Clemente, R., e.a. (2005). Neurologic soft signs in schizophrenic patients treated with conventional and atypical antipsychotics. Journal Clinical Psychopharmacology, 25, 372-375.
7. Bilder, R.M., Goldman, R.S., Volavka, J., e.a. (2002). Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. The American Journal of Psychiatry, 159, 1018-1028.
8. Bleuler, E. (1950). Dementia Praecox or Group of Schizophrenias. (J. Zinkin, Vert.). New York: International Universities Press.
9. Boks, M.P., Liddle, P.F., Burgerhof, J.G., e.a. (2004). Neurological soft signs discriminating mood disorders from first episode schizophrenia. Acta Psychiatrica Scandinavica, 110, 29-35.
10. Boks, M.P., Selten, J.P., Leask, S., e.a. (2006). The 2-year stability of neurological soft signs after a first episode of non-affective psychosis. European Psychiatry, 21, 288-290.
11. Bräunig, P., Krüger, S., Shugar, G., e.a. (2000). The catatonia rating scale I - development, reliability, and use. Comprehensive Psychiatry, 41, 147-158.
12. Browne, S., Clarke, M., Gervin, M., e.a. (2000). Dererminants of neurological dysfunction in first episode schizophrenia. Psychological Medicine, 30, 1433-1441.
13. Buchanan, R.W., & Heinrichs, D.W. (1989). The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Research, 27, 335-350.
14. Bush, G., Fink, M., Petrides, G., e.a. (1996). Catatonia. I. Rating scale and standardized examination. Acta Psychiatrica Scandinavica, 93, 129-136.
15. Bush, G., Petrides, G., Francis, A. (1997). Catatonia and other motor syndromes in a chronically hospitalized psychiatric population. Schizophrenia Research, 27, 83-92.
16. Caligiuri, M.P., Lohr, J.B., Jeste, D.V. (1993). Parkinsonism in neuroleptic-naive schizophrenic patients. The American Journal of Psychiatry, 150, 1343-1348.
17. Chen, E.Y., Shapleske, J., Luque, R., e.a. (1995). The Cambridge Neurological Inventory: a clinical instrument for assessment of soft neurological signs in psychiatric patients. Psychiatry Research, 56, 183-204.
18. Chen, E.Y., Kwok, C.L., Au, J.W., e.a. (2000). Progressive deterioration of soft neurological signs in chronic schizophrenic patients. Acta Psychiatrica Scandinavica, 102, 342-349.
19. Chen, E.Y., Hui, C.L., Chan, R.C., e.a. (2005). A 3-year prospective study of neurological soft signs in first-episode schizophrenia. Schizophrenia Research, 75, 45-54.
20. Cuesta, M.J., Peralta, V., Zarzuela, A., e.a. (2002). Neurological soft-signs in psychosis: threshold criteria for discriminating normal controls and for predicting cognitive impairment. Schizophrenia Research, 58, 263-271.
21. Danckert, J., Saoud, M., Maruff, P. (2004). Attention, motor control and motor imagery in schizophrenia: implications for the role of the parietal cortex. Schizophrenia Research, 70, 241-261.
22. Das, M., Kumari, V., Soni, W., e.a. (2004). Neurological soft signs and their relationship to cognitive and clinical efficacy of atypical antipsychotics in schizophrenia. Schizophrenia Bulletin, 30, 241-253.
23. Eede, F. Van Den, Van Hecke, J., Van Dalfsen, A., e.a. (2005). The use of atypical antipsychotics in the treatment of catatonia. European Psychiatry, 20, 422-429.
24. Farde, L., Nordström, A.L., Wiesel, F.A., e.a. (1992). Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Archives of General Psychiatry, 49, 538-544.
25. Fenton, W.S. (2000). Prevalence of spontaneous dyskinesia in schizophrenia. The Journal of Clinical Psychiatry, 61 (Suppl. 4), S10-S14.
26. Fink, M., & Taylor, M.A. (2001). The many varieties of catatonia. European Archives of Psychiatry and Clinical Neuroscience, 251 (Suppl. 1), 18-113.
27. Fink, M., & Taylor, M.A. (2003). Catatonia: a clinician's guide to diagnosis and treatment. Cambridge: Cambridge University Press.
28. Fuller, R., & Jahanshahi, M. (1999). Concurrent performance of motor tasks and processing capacity in patients with schizophrenia. Journal of Neurology, Neurosurgery, and Psychiatry, 66, 668-671.
29. Gerlach, J. (1988). Tardive dyskinesia. Pathophysiological mechanisms and clinical trials. Encephale, 14 Spec No, 227-232.
30. Gold, S., Arndt, S., Nopoulos, P., e.a. (1999). Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia. The American Journal of Psychiatry, 156, 1342-1348.
31. Green, M.F., Kern, R.S., & Heaton, R.K. (2004). Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophrenia Research, 72, 41-51.
32. Harten, P.N. van (2004). Meetinstrumenten bij motorische bijwerkingen. Tijdschrift voor psychiatrie, 46, 711-715.
33. Harten, P.N. van (2005). Katatonie, een syndroom om te herinneren. Tijdschrift voor psychiatrie, 47, 371-382.
34. Heijden, F.M. van der, Tuinier, S., Arts, N.J., e.a. (2005). Catatonia: disappeared or under-diagnosed? Psychopathology, 38, 3-8.
35. Hokama, H., Shenton, M.E., Nestor, P.G., e.a. (1995). Caudate, putamen, and globus pallidus volume in schizophrenia: a quantitative MRI study. Psychiatry Research, 61, 209-229.
36. Holthausen, E.A., Wiersma, D., Knegtering RH, e.a. (1999). Psychopathology and cognition in schizophrenia spectrum disorders: the role of depressive symptoms. Schizophrenia Research, 39, 65-71.
37. Jahn, T., Hubmann, W., Karr, M., e.a. (2006a). Motoric neurological soft signs and psychopathological symptoms in schizophrenic psychoses. Psychiatry Research, 142, 191-199.
38. Jahn, T., Cohen, R., Hubmann, W., e.a. (2006b). The Brief Motor Scale (BMS) for the assessment of motor soft signs in schizophrenic psychoses and other psychiatric disorders. Psychiatry Research, 142, 177-189.
39. Jogems-Kosterman, B.J. (2004). Psychomotor slowing and planning deficits in schizophrenia, (proefschrift). Nijmegen: Radboud Universiteit.
40. Kahlbaum, K.L. (1874). Die Katatonie oder das Spannungsirresein. Eine klinischer Form psychischer Krankheit. Berlin: Hirschwald.
41. King, D.J. (1990). The effect of neuroleptics on cognitive and psychomotor function. The British Journal of Psychiatry, 157, 799-811.
42. Kraepelin, E. (1971). Dementia Praecox and paraphrenia. (R.M. Barclay, Vert.). New York: Krieger.
43. Krüger, S., Bagby, R.M., Höffler, J., e.a. (2003). Factor analysis of the catatonia rating scale and catatonic symptom distribution across four diagnostic groups. Comprehensive Psychiatry, 44, 472-482.
44. Lane, A., Colgan, K., Moynihan, F., e.a. (1996). Schizophrenia and neurological soft signs: gender differences in clinical correlates and antecedent factors. Psychiatry Research, 64, 105-114.
45. Leonhard, K. (1999). Classification of endoaenous psychoses and their differentiated etiology. (2de, herziene en uitgebreide druk) (H. Beckmann, Red.; C.H. Cahn, Vert.). Vienna: Springer Verlag.
46. Mattay, V.S., & Casey, D.E. (2003). Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia. In: S.R. Hitsch, & D.R. Weinberger. (Red.), Schizophrenia (pp. 552-572). Oxford: Blackwell Science Ltd.
47. Medalia, A., Gold, J., Merriam, A. (1988). The effects of neuroleptics on neuropsychological test results of schizophrenics. Archives of Clinical Neuropsychology, 3, 249-271.
48. Mohr, F., Hubmann, W., Albus, M., e.a. (2003). Neurological soft signs and neuropsychological performance in patients with first episode schizophrenia. Psychiatry Research, 121, 21-30.
49. Morrens, M., Hulstijn, W., Van Hecke, J., e.a. (2006a). Sensorimotor and cognitive slowing in schizophrenia as measured by the Symbol Digit Substitution Test. Journal of Psychiatric Research, 40, 200-206.
50. Morrens, M., Hulstijn, W., Lewi, P.J., e.a. (2006b). Stereotypy in schizophrenia. Schizophrenia Research, 84, 397-404.
51. Morrens, M., Hulstijn, W., Matton, C., e.a. (ter perse). Delineating psychomotor slowing from processing speed in schizophrenia. Cognitive neuropsychiatry.
52. Morrens, M., Hulstijn, W., Sabbe, B. (2007a). Psychomotor slowing in schizophrenia. Schizophrenia Bulletin, 33, 1038-1053.
53. Morrens, M., Wezenberg, E., Verkes, R.J., e.a. (2007b). Psychomotor and memory effects of halopetidol, olanzapine, and paroxetine in healthy subjects after short-term administration. Journal of Clinical Psychopharmacology, 27, 15-21.
54. Müller, J.L., Rôder, C., Schuierer, G., e.a. (2002). Subcortical overactivation in untreated schizophrenic patients: a functional magnetic resonance image finger-tapping study. Psychiatry and Clinical Neurosciences, 56, 77-84.
55. Northoff, G., Koch, A., Wenke, J., e.a. (1999). Catatonia as a psychomotor syndrome: a rating scale and extrapyramidal motor symptoms. Movement Disorders, 14, 404-416.
56. Os, J. van, Walsh, E., van Horn, E. e.a. (2000). Changes in negative symptoms and the risk of tardive dyskinesia: a longitudinal study. UK700 Group. Acta Psychiatrica Scandinavica, 101, 300-306.
57. Peralta, V., Cuesta, M.J., Serrano, J.F., e.a. (2001). Classification issues in catatonia. European archives of psychiatry and clinical neuroscience, 251 (Suppl. 1), 114-116.
58. Pfuhlmann, B., Stöber, G. (2001). The different conceptions of catatonia: historical overview and critical discussion. European Archives of Psychiatry and Clinical Neurosciences, 251, 14-7.
59. Prikryl, R., Ceskova, E., Kasparek, T., e.a. (2006). Neurological soft signs, clinical symptoms and treatment reactivity in patients suffering from first episode schizophrenia. Journal of Psychiatric Research, 40, 141-146.
60. Sachdev, P.S. (2000). The current status of tardive dyskinesia. The Australian and New Zealand Journal of Psychiatry, 34, 355-369.
61. Schubert, E.W., & McNeil, T.F. (2005). Neuropsychological impairment and its neurological correlates in adult offspring with heightened risk for schizophrenia and affective psychosis. The American Joumal of Psychiatry, 162, 758-766.
62. Stompe, T., Ortwein-Swoboda, G., Ritter, K., e.a. (2002). Are we witnessing the disappearance of catatonic schizophrenia? Comprehensive Psychiatry, 43, 167-174.
63. Tosato, S., & Dazzan, P. (2005). The psychopathology of schizophrenia and the presence of neurological soft signs: a review. Current Opinion in Psychiatry, 18, 285-288.
64. Ungvari, G.S., Kau, L.S., Wai-Kwong, T., e.a. (2001). The pharmacological Treatment of catatonia: an overview. European Archives of Psychiatry and Clinical Neuroscience, 251 (Suppl. 1), I31-I34.
65. Ungvari, G.S., Leung, S.K., Ng, F.S., e.a. (2005). Schizophrenia with prominent catatonic features ('catatonic schizophrenia'): I. Demographic and clinical correlates in the chronic phase. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 29, 27-38.
66. Venkatasubramanian, G., Latha, V., Gangadhar, B.N., e.a. (2003). Neurological soft signs in never-treated schizophrenia. Acta Psychiatrica Scandinavica, 108, 144-146.
67. Waddington, J. L., & Youssef, H. A. (1996). Cognitive dysfunction in chronic schizophrenia followed prospectively over 10 years and its longitudinal relationship to the emergence of tardive dyskinesia. Psychological Medicine, 26, 681-688.
68. Walker, E., Savoie, T., & Davis, D. (1994). Neuromotor precursors of schizophrenia. Schizophrenia Bulletin, 20, 441-451.
69. Wernicke, C. (1990). Grundriß der Psychiatrie in klinischen Vorlesungen. Leipzig: Thieme.
70. Whitty, P., Clarke, M., Browne, S., e.a. (2003). Prospective evaluation of neurological soft signs in first-episode schizophrenia in relation to psychopathology: state versus trait phenomena. Psychological Medicine, 33, 1479-1484.
71. Whitty, P., Clarke, M., McTigue, O., e.a. (2006). Diagnostic specificity and predictors of neurological soft signs in schizophrenia, bipolar disorder and other psychoses over the first 4 years of illness. Schizophrenia Research, 86, 110-117.
72. Wolff, A.L., & O'Driscoll, G.A. (1999). Motor deficits and schizophrenia: the evidence from neuroleptic-naïve patients and populations at risk. Journal of Psychiatry and Neuroscience, 24, 304-314.
73. Yang, Y.K., Yeh, T.L., Chiu, N.T., e.a. (2004). Association between cognitive performance and striaral dopamine binding is higher in timing and motor tasks in patients with schizophrenia. Psychiatry Research, 131, 209-216.